Company Filing History:
2 out of 11 
1 out of 12 
1 out of 676 
Years Active: 2001-2014
Title: Banjamin Pless: Innovator in Electrophysiological Disease Treatment
Introduction
Banjamin Pless, an inventive mind based in Atherton, California, has made significant contributions to the field of electrophysiology. With a total of four patents to his name, his work primarily focuses on innovating apparatuses and methods for the diagnosis and therapy of electrophysiological conditions, particularly atrial fibrillation.
Latest Patents
Among his most recent innovations, Banjamin Pless has developed an apparatus and method for diagnosing and treating electrophysiological diseases. This invention provides tools for mapping conduction pathways and creating lesions in the heart wall to effectively treat atrial fibrillation. The apparatus features at least one epicardial ablation probe equipped with multiple electrodes that are instrumental in lesion creation. This technology aims to form a lesion that electrically isolates the pulmonary veins from the surrounding myocardium, showcasing a pivotal advancement in cardiac treatment methodologies.
Career Highlights
Throughout his career, Banjamin Pless has worked with notable companies in the medical field, including Epicor, Inc. and Epicor Medical, Inc. His role in these organizations has allowed him to leverage his skills in developing innovative solutions that address critical health issues.
Collaborations
Banjamin has collaborated with distinguished professionals in his field, including Matthias Vaska and David A. Gallup. These collaborations have fostered an exchange of ideas and expertise, further enhancing the impact of his inventions on patient care.
Conclusion
In summary, Banjamin Pless stands out as a key figure in the advancement of electrophysiological disease treatment. His innovative apparatuses and methodologies not only contribute to the medical community but also offer hope for improved therapies for those suffering from heart conditions like atrial fibrillation. With a continued commitment to innovation, he is set to influence the field further and pave the way for future breakthroughs.